Hippel James
Transaction: 07/29/2026
SELL
Change
-62,068
Price
$47.60
Filing
07/31/2026
Type
SELL
Bio-Techne Corporation
TECH • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$11.30B
Growth
12.5%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 15.0%Positive free cash flow · 1.69Consistent free cash flow · 5/5Manageable debt level · 0.13Healthy liquidity · 4.55
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:46 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$11.30B
52W Range43.20 - 72.39
Beta1.28
Gross Margin65.77%
Oper. Margin20.73%
Profit Margin14.97%
Debt/Eq0.13
Current Ratio4.55
Quick Ratio3.35
Revenue 5Y12.52%
Price$0.00
Change0.00%
Market Cap$11.30B
52W Range43.20 - 72.39
Beta1.28
Gross Margin65.77%
Oper. Margin20.73%
Profit Margin14.97%
Debt/Eq0.13
Current Ratio4.55
Quick Ratio3.35
Revenue 5Y12.52%
Target$65.78
Target Median$73.00
Target Range50.00 - 73.00
Volume1.97M
Avg Volume4.20M
EPS Surprise-0.02
Investment DNA
How strong this company looks for long-term investors
66
out of 100
Business Quality
Margins, moat, returns
78/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
35/100
Price Attractiveness
Cheap or expensive today
31/100
Why this score▼
Stable or improving margins · 15.0%Positive free cash flow · 1.69Consistent free cash flow · 5/5Manageable debt level · 0.13Healthy liquidity · 4.55Expensive earnings multiple · 60.38
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$50.00
Mean
$65.78
Median
$73.00
High
$73.00
Insider Transactions
Recent executive and insider activity
Hippel James
Transaction: 07/29/2026
SELL
Change
-51,024
Price
$72.03
Filing
07/31/2026
Type
SELL
Kelderman Kim
Transaction: 07/28/2026
SELL
Change
-35,000
Price
$47.60
Filing
07/30/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hippel James | SELL | -62,068 | $47.60 | 07/29/2026 | 07/31/2026 |
| Hippel James | SELL | -51,024 | $72.03 | 07/29/2026 | 07/31/2026 |
| Kelderman Kim | SELL | -35,000 | $47.60 | 07/28/2026 | 07/30/2026 |
| Kelderman Kim | SELL | -28,686 | $72.07 | 07/28/2026 | 07/30/2026 |
| Bohnen Shane | SELL | -448 | $47.60 | 07/23/2026 | 07/27/2026 |
| Bohnen Shane | SELL | -344 | $71.77 | 07/23/2026 | 07/27/2026 |
| Crouse Steven C. | SELL | -600 | Not reported | 06/02/2026 | 06/04/2026 |
| Crouse Steven C. | SELL | -216 | $49.77 | 06/02/2026 | 06/04/2026 |
| Herr Amy E. | SELL | -6,636 | $47.60 | 05/08/2026 | 05/12/2026 |
| Herr Amy E. | SELL | -6,636 | $48.28 | 05/08/2026 | 05/12/2026 |
| Kelderman Kim | SELL | -26,692 | $47.60 | 05/05/2026 | 05/07/2026 |
| Kelderman Kim | SELL | -23,951 | $56.68 | 05/05/2026 | 05/07/2026 |
| Bohnen Shane | SELL | -8,400 | $47.60 | 05/05/2026 | 05/07/2026 |
| Bohnen Shane | SELL | -7,055 | $56.68 | 05/05/2026 | 05/07/2026 |
| Hippel James | SELL | -62,000 | $47.60 | 05/05/2026 | 05/07/2026 |
| Hippel James | SELL | -56,955 | $56.68 | 05/05/2026 | 05/07/2026 |
| Crouse Steven C. | SELL | -794 | Not reported | 05/01/2026 | 05/05/2026 |
| Crouse Steven C. | SELL | -311 | $55.02 | 05/01/2026 | 05/05/2026 |
| Hippel James | SELL | -62,000 | $47.60 | 04/22/2026 | 04/24/2026 |
| Hippel James | SELL | -56,097 | $58.58 | 04/22/2026 | 04/24/2026 |